Menorrhagia Clinical Trials

4 recruiting

Menorrhagia Trials at a Glance

8 actively recruiting trials for menorrhagia are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Beijing, Cincinnati, and Austin. Lead sponsors running menorrhagia studies include Duke University, JW Pharmaceutical, and Channel Medsystems.

Browse menorrhagia trials by phase

Treatments under study

About Menorrhagia Clinical Trials

Looking for clinical trials for Menorrhagia? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Menorrhagia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Menorrhagia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

Uterine FibroidsMenorrhagia
JW Pharmaceutical254 enrolled1 locationNCT07378098
Recruiting

Reframing Endometrial Physiology by Advanced Integrated Research

Menorrhagia Due to Benign Causes
University Hospital Southampton NHS Foundation Trust100 enrolled1 locationNCT07557992
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting

Multicenter Observational Cohort Study on the Epidemiology of Therapeutic Strategies in Patients Affected by Adenomyosis

Adenomyosis of UterusUterine DiseasesGynecologic Diseases+1 more
SCHETTINI SERGIO200 enrolled1 locationNCT07478614
Recruiting
Phase 2

Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia

Uterine Fibroids With Menorrhagia
Shenzhen Kangzhe Biotechnology Co., Ltd.120 enrolled1 locationNCT07402369
Recruiting

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

Abnormal Uterine BleedingHeavy Menstrual BleedingMenorrhagia
Channel Medsystems300 enrolled2 locationsNCT05922657
Recruiting
Not Applicable

Effects of Resistance Training Intensity on Cardiovascular Parameters of Hypertensive Women

Cardiovascular DiseasesArterial HypertensionPostmenopausal; Menorrhagia
University of Sao Paulo24 enrolled1 locationNCT06538454
Recruiting
Phase 2Phase 3

A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids

Uterine Fibroids With Menorrhagia
Jiangsu HengRui Medicine Co., Ltd.357 enrolled1 locationNCT05442827